The proposal would provide $20 million per year (ongoing, not indexed) to improve fetal alcohol syndrome disorder (FAS-D) diagnosis and treatment.

The proposal would start from 1 July 2026.

The proposal would provide $6 million over 3 years to the Alannah and Madeline Foundation to keep children safe from online harm.

The proposal would be non-ongoing, distribute funding evenly over 3 years and start on 1 July 2026.

The proposal would provide $6 million over 3 years to the Alannah and Madeline Foundation to keep children safe from online harm.

The proposal would be non-ongoing, distribute funding evenly over 3 years and start on 1 July 2026.

The proposal would provide $6 million over 3 years to the Alannah and Madeline Foundation to keep children safe from online harm.

The proposal would be non-ongoing, distribute funding evenly over 3 years and start on 1 July 2026.

The proposal would provide $6 million over 3 years to the Alannah and Madeline Foundation to keep children safe from online harm.

The proposal would be non-ongoing, distribute funding evenly over 3 years and start on 1 July 2026.

The proposal would provide $6 million over 3 years to the Alannah and Madeline Foundation to keep children safe from online harm.

The proposal would be non-ongoing, distribute funding evenly over 3 years and start on 1 July 2026.

The proposal would provide $6 million over 3 years to the Alannah and Madeline Foundation to keep children safe from online harm.

The proposal would be non-ongoing, distribute funding evenly over 3 years and start on 1 July 2026.

The proposal would provide $6 million over 3 years to the Alannah and Madeline Foundation to keep children safe from online harm.

The proposal would be non-ongoing, distribute funding evenly over 3 years and start on 1 July 2026.

The proposal would provide $6 million over 3 years to the Alannah and Madeline Foundation to keep children safe from online harm.

The proposal would be non-ongoing, distribute funding evenly over 3 years and start on 1 July 2026.

The proposal would provide $5 million in 2025-26 to review women-specific health items on the Medicare Benefits Schedule (MBS) and corresponding treatments on the Pharmaceutical Benefits Schedule (PBS). This review would identify best practice women-specific medical services which should be included, and ensure clinically effective services and treatments remain affordable and accessible to better support women’s health and wellbeing.

The proposal would be non-ongoing and start from 1 July 2025.